Literature DB >> 6101757

Reversal of ethanol-induced coma with naloxone.

D B Jefferys, R J Flanagan, G N Volans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6101757     DOI: 10.1016/s0140-6736(80)90800-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Endorphins: the basis of pleasure?

Authors:  C H Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

2.  Beta-endorphin-immunoreactivity in the ventricular CSF and plasma of comatose patients.

Authors:  E Hamel; B Allolio
Journal:  Neurosurg Rev       Date:  1989       Impact factor: 3.042

3.  Endorphin levels in human cerebrospinal fluid during alcohol intoxication and withdrawal.

Authors:  S Borg; H Kvande; U Rydberg; L Terenius; A Wahlström
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Drugs and alcohol.

Authors: 
Journal:  Br Med J       Date:  1980-02-23

Review 5.  Acute ethanol poisoning and the ethanol withdrawal syndrome.

Authors:  B Adinoff; G H Bone; M Linnoila
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

6.  The mechanism of the antagonism by naloxone of acute alcohol intoxication.

Authors:  A A Badawy; M Evans
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

7.  Alcohol induced discoordination is not reversed by naloxone.

Authors:  D M Catley; C Jordan; C D Frith; J R Lehane; A M Rhodes; J G Jones
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 8.  New and experimental therapeutic roles for naloxone and related opioid antagonists.

Authors:  L F McNicholas; W R Martin
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

9.  Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice.

Authors:  K Kiianmaa; P L Hoffman; B Tabakoff
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.